For example, high levels of N1- and N2-SRC expression are correlated with a positive prognosis in neuroblastoma (Bjelfman et al., 1990; Matsunaga et al., 1994), a developmental cancer of neural crest origin, in which splicing is altered (Shi et al., 2021). This evidence concerns the gene SRC and neuroblastoma.